Interventions for cannabis misuse

Advances in Psychiatric Treatment

Volumn 12, Issue 6, 2006, Pages 432-439

  Maddock, Clementine ^a   Babbs, Michelle ^b  

^a SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^b Lambeth Cannabis Clinic   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 38649101989     PISSN: 13555146     EISSN: None     Source Type: Journal    
DOI: 10.1192/apt.12.6.432     Document Type: Review

References (33)

1. Advisory Council on the Misuse of Drugs (2002) The Classification of Cannabis under the Misuse of Drugs Act 1971. London: Home Office.
2. Advisory Council on the Misuse of Drugs (2005) Further Consideration of the Classification of Cannabis under the Misuse of Drugs Act 1971. London: Home Office.
3. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn). Washington: American Psychiatric Association.
4. Arendt, M., Rosenberg, R., Foldager, L., et al (2005) Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases. British Journal of Psychiatry, 187, 510-515.
5. Arseneault, L., Cannon, M., Witton, J., et al (2004) Causal association between cannabis and psychosis: examination of the evidence. British Journal of Psychiatry, 184, 110-117.
6. Baker, A., Bucci, S., Lewin, T. J., et al (2006) Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders. British Journal of Psychiatry, 188, 439-448.
7. Budney, A. J., Higgins, S. T., Radanovich, K. J., et al (2000) Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. Journal of Consulting and Clinical Psychology, 68, 1051-1061.
8. Caspi, A., Moffitt, T. E., Cannon, M., et al (2005) Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene x environment interaction. Biological Psychiatry, 57, 1117-1127.
9. Chivite-Matthews, N., Richardson, A., O'Shea, J., et al (2005) Drug Misuse Declared: Findings from the 2003/04 British Crime Survey. London: Home Office.
10. Copeland, J., Swift, W., Roffman, R., et al (2001) A randomised controlled trial of brief cognitive-behavioural interventions for cannabis use disorder. Journal of Substance Abuse Treatment, 21, 55-64.
11. Coulthard, M., Farrell, M., Singleton, N., et al (2002) Tobacco, Alcohol and Drug Use and Mental Health. London: TSO (The Stationery Office).
12. Dennis, M., Godley, S., Diamond, G., et al (2004) The Cannabis Youth Treatment (CYT) study: main findings from two randomized trials. Journal of Substance Abuse Treatment, 27, 197-213.
13. D'Souza, C., Cho, H. S., Perry, E., et al (2004) A cannabinoid model psychosis, dopamine-cannabinoid interactions and implications for schizophrenia. In Marijuana and Madness (eds D. J. Castle & R. Murray), pp. 142-165. Cambridge: Cambridge University Press.
14. Green, A. (2005) Schizophrenia and comorbid substance use disorder: effects of antipsychotics. Journal of Clinical Psychiatry, 66 (suppl. 6), 21-26.
15. Green, B., Kavanagh, D. J. & Young, R. M. (2004) Reasons for cannabis use in men with and without psychosis. Drug and Alcohol Review, 23, 445-453.
16. Haddock, G., Barrowclough, C., Tarrier, N., et al (2003) Cognitive-behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18-month outcomes of a randomised controlled trial. British Journal of Psychiatry, 183, 418-426.
17. Hser, Y., Grella, C. E., Hubbard, R. L., et al (2001) An evaluation of drug treatments for adolescents in 4 US cities. Archives of General Psychiatry, 58, 689-695.
18. Huestis, M. A., Gorelick, D. A., Heishman, S. J., et al (2001) Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Archives of General Psychiatry, 58, 322-328.
19. Iversen, L. (2005) Long-term effects of exposure to cannabis. Current Opinion in Pharmacology, 5, 69-72.
20. Kendell, R. (2003) Cannabis condemned: the proscription of Indian Hemp. Addiction, 98, 143-151.
21. Levin, F. R., McDowell, D., Evans, S. M., et al (2004) Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium. American Journal of Addiction, 13, 21-32.
22. Marijuana Treatment Project Research Group (2004) Brief treatments for cannabis dependence: findings from a randomized multisite trial. Journal of Consulting and Clinical Psychology, 72, 455-466.
23. Marlatt, G. A. & Gordon, J. R. (1985) Relapse Prevention: A Self-Control Strategy for the Maintenance of Behaviour Change. New York: Guilford Press.
24. Martin, G., Copeland, J. & Swift, W. (2005) The Adolescent Cannabis Check-Up: feasibility of a brief intervention for young cannabis users. Journal of Substance Abuse Treatment, 29, 207-213.
25. McCambridge, J. & Strang, J. (2004) The efficacy of single-session motivational interviewing in reducing drug consumption and perceptions of drug-related risk and harm among young people: results from a multi-site cluster randomised trial. Addiction, 99, 39-52.
26. McRae, A. L., Budney, A. J. & Brady, K. T. (2003) Treatment of marijuana dependence: a review of the literature. Journal of Substance Abuse Treatment, 24, 369-376.
27. Miller, W. R. & Rollnick, S. (2002) Motivational Interviewing: Preparing People for Change. New York: Guilford Press.
28. Stephens, R. S., Roffman, R. A. & Simpson, E. E. (1994) Treatment of adult marijuana dependence: a test of the relapse prevention model. Journal of Consulting and Clinical Psychology, 62, 92-99.
29. Stephens, R. S., Roffman, R. A. & Curtin, L. (2000) Comparison of extended versus brief treatments for marijuana use. Journal of Consulting and Clinical Psychology, 68, 898-908.
30. Treffert, D. (1978) Marijuana use in schizophrenia: a clear hazard. American Journal of Psychiatry, 135, 1213-1215.
31. Turner, W. M. & Tsuang M. T. (1990) Impact of substance abuse on the course and outcome of schizophrenia. Schizophrenia Bulletin, 16, 1990.
32. World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: WHO.
33. Wright, F. D., Beck, A. T., Newman, C. F., et al (1993) Cognitive Therapy of Substance Abuse. New York: Guilford Press.